Epoetin alfa is used to treat anemia for people with chronic kidney disease (CKD), because their kidneys are unable to produce enough natural erythropoietin on their own. It is also used to treat people with cancer who develop anemia because of chemotherapy treatment.

2025年1月7日 · Eprex regulates erythropoiesis by stimulating the differentiation and proliferation of erythroid precursors, stimulating the release of reticulocytes into the circulation, and …

EPREX should be used with caution in patients with epilepsy, history of seizures, or medical conditions associated with a predisposition to seizure activity such as CNS infections and brain metastases.

is by prescribing EPREX. This medicine stimulates your bone marrow to produce more red blood cells, helpi g to treat your anaemia. EPREX can also be used to treat anaemia if you are receiving chemotherapy for cancer and your doctor decides that a blood transf

2017年3月24日 · EPREX ® (epoetin alfa) is an erythreopoiesis-stimulating agent (ESA) that works by stimulating the production of red blood cells (RBCs). 6 ESAs are an important treatment option for patients with certain types of anaemia, including chemotherapy-induced anaemia and anaemia due to chronic kidney disease.

2025年3月18日 · EPREX is used to treat the anaemia associated with kidney disease. If you have kidney disease, your kidney may not produce enough erythropoietin (necessary for red blood...

We are giving you Eprex® to help your body produce more red blood cells. This may help decrease your need for a blood transfusion. What is Eprex®? Eprex® is a man-made version of erythropoietin. In your body, your kidneys naturally produce erythropoietin when you have low …

2025年2月4日 · Eprex 40000 IU/ml solution for injection in pre-filled syringe - Summary of Product Characteristics (SmPC) by Janssen-Cilag Ltd (a Johnson & Johnson Company)

Eprex. This has been reported in patients receiving Eprex. Any patient who develops a sudden loss of response to Eprex, accompanied by severe anemia and low reticulocyte count should be evaluated for the etiology of loss of effect, including

Epoetin alfa is used to treat anemia for people with chronic kidney disease (CKD), because their kidneys are unable to produce enough natural erythropoietin on their own. It is also used to treat people with cancer who develop anemia because of chemotherapy treatment.